Mira Pharmaceuticals Common Stock Performance
| MIRA Stock | 1.19 0.02 1.65% |
The company secures a Beta (Market Risk) of 0.69, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MIRA Pharmaceuticals' returns are expected to increase less than the market. However, during the bear market, the loss of holding MIRA Pharmaceuticals is expected to be smaller as well. At this point, MIRA Pharmaceuticals has a negative expected return of -0.26%. Please make sure to verify MIRA Pharmaceuticals' day median price, period momentum indicator, as well as the relationship between the accumulation distribution and potential upside , to decide if MIRA Pharmaceuticals performance from the past will be repeated at future time.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days MIRA Pharmaceuticals Common has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
1 | Mira Pharmaceuticals increases at-the-market offering by 15.2 million - Investing.com | 12/05/2025 |
2 | Is MIRA Pharmaceuticals Inc. stock attractive for growth ETFs - 2025 Price Targets Long Hold Capital Preservation Plans - ulpravda.ru | 12/18/2025 |
3 | Will MIRA Pharmaceuticals Inc. stock maintain dividend yield - Wide Width Options HOKA model picks for your routine - ulpravda.ru | 01/09/2026 |
4 | Psychedelic Analyst initiates Atai Beckley with Buy rating - TipRanks | 01/22/2026 |
5 | MIRA Pharmaceuticals Shares Down 6.6 percent Whats Next | 02/06/2026 |
6 | Visionstate Repositions Under MIRA Compliance Platform and Reports Subscription Growth | 02/19/2026 |
MIRA Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 143.00 in MIRA Pharmaceuticals Common on November 23, 2025 and sell it today you would lose (24.00) from holding MIRA Pharmaceuticals Common or give up 16.78% of portfolio value over 90 days. MIRA Pharmaceuticals Common is currently does not generate positive expected returns and assumes 2.9631% risk (volatility on return distribution) over the 90 days horizon. In different words, 26% of stocks are less volatile than MIRA, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
MIRA Pharmaceuticals Target Price Odds to finish over Current Price
The tendency of MIRA Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 1.19 | 90 days | 1.19 | under 95 |
Based on a normal probability distribution, the odds of MIRA Pharmaceuticals to move above the current price in 90 days from now is under 95 (This MIRA Pharmaceuticals Common probability density function shows the probability of MIRA Stock to fall within a particular range of prices over 90 days) .
MIRA Pharmaceuticals Price Density |
| Price |
Predictive Modules for MIRA Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as MIRA Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.MIRA Pharmaceuticals Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. MIRA Pharmaceuticals is not an exception. The market had few large corrections towards the MIRA Pharmaceuticals' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold MIRA Pharmaceuticals Common, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of MIRA Pharmaceuticals within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.24 | |
β | Beta against Dow Jones | 0.69 | |
σ | Overall volatility | 0.13 | |
Ir | Information ratio | -0.09 |
MIRA Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of MIRA Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for MIRA Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| MIRA Pharmaceuticals generated a negative expected return over the last 90 days | |
| MIRA Pharmaceuticals may become a speculative penny stock | |
| Net Loss for the year was (7.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MIRA Pharmaceuticals generates negative cash flow from operations | |
| MIRA Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| About 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Visionstate Repositions Under MIRA Compliance Platform and Reports Subscription Growth |
MIRA Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of MIRA Stock often depends not only on the future outlook of the current and potential MIRA Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MIRA Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 15.4 M | |
| Cash And Short Term Investments | 2.8 M |
MIRA Pharmaceuticals Fundamentals Growth
MIRA Stock prices reflect investors' perceptions of the future prospects and financial health of MIRA Pharmaceuticals, and MIRA Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on MIRA Stock performance.
| Return On Equity | -1.23 | ||||
| Return On Asset | -0.75 | ||||
| Current Valuation | 45.05 M | ||||
| Shares Outstanding | 41.88 M | ||||
| Price To Book | 6.38 X | ||||
| EBITDA | (8.02 M) | ||||
| Net Income | (7.85 M) | ||||
| Total Debt | 723.35 K | ||||
| Book Value Per Share | 0.19 X | ||||
| Cash Flow From Operations | (5.56 M) | ||||
| Earnings Per Share | (1.60) X | ||||
| Market Capitalization | 50.46 M | ||||
| Total Asset | 2.92 M | ||||
| Retained Earnings | (29.14 M) | ||||
| Working Capital | 2.16 M | ||||
About MIRA Pharmaceuticals Performance
By analyzing MIRA Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into MIRA Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if MIRA Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if MIRA Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (3.09) | (3.24) | |
| Return On Capital Employed | (4.19) | (3.98) | |
| Return On Assets | (3.09) | (3.24) | |
| Return On Equity | (4.11) | (3.90) |
Things to note about MIRA Pharmaceuticals performance evaluation
Checking the ongoing alerts about MIRA Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MIRA Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MIRA Pharmaceuticals generated a negative expected return over the last 90 days | |
| MIRA Pharmaceuticals may become a speculative penny stock | |
| Net Loss for the year was (7.85 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| MIRA Pharmaceuticals generates negative cash flow from operations | |
| MIRA Pharmaceuticals has a frail financial position based on the latest SEC disclosures | |
| About 17.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from finance.yahoo.com: Visionstate Repositions Under MIRA Compliance Platform and Reports Subscription Growth |
- Analyzing MIRA Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MIRA Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining MIRA Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MIRA Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of MIRA Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MIRA Pharmaceuticals' stock. These opinions can provide insight into MIRA Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for MIRA Stock analysis
When running MIRA Pharmaceuticals' price analysis, check to measure MIRA Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MIRA Pharmaceuticals is operating at the current time. Most of MIRA Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of MIRA Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MIRA Pharmaceuticals' price. Additionally, you may evaluate how the addition of MIRA Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |